These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20361941)

  • 1. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
    Wu ZZ; Lu HP; Chao CC
    Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
    Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codominance of cisplatin resistance in somatic cell hybrids.
    Ying YL; Shen DW; Liang XJ; Gottesman MM
    J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells.
    Cheng TC; Manorek G; Samimi G; Lin X; Berry CC; Howell SB
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):384-95. PubMed ID: 16404635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate genes for cross-resistance against DNA-damaging drugs.
    Wittig R; Nessling M; Will RD; Mollenhauer J; Salowsky R; Münstermann E; Schick M; Helmbach H; Gschwendt B; Korn B; Kioschis P; Lichter P; Schadendorf D; Poustka A
    Cancer Res; 2002 Nov; 62(22):6698-705. PubMed ID: 12438269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cells acquire resistance to anticancer drugs: an update.
    Lu HP; Chao CC
    Biomed J; 2012; 35(6):464-72. PubMed ID: 23442359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
    Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G
    Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
    Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
    Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated transduction of a short hairpin RNA gene for GRP78 fails to downregulate GRP78 expression but leads to cisplatin sensitization in HeLa cells.
    Suzuki T; Lu J; Hu G; Kita K; Suzuki N
    Oncol Rep; 2011 Mar; 25(3):879-85. PubMed ID: 21225231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
    Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy.
    Schulte JH; Schramm A; Pressel T; Klein-Hitpass L; Kremens B; Eils J; Havers W; Eggert A
    Klin Padiatr; 2003; 215(6):298-302. PubMed ID: 14677092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
    Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
    Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
    Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
    Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.